Adhesion Formation
Executive Summary
Intraabdominal adhesions represent a major clinical challenge, occurring in 50% to 95% of patients following abdominal surgery. They are the primary cause of approximately 75% of small bowel obstructions (SBO) and a significant contributor to female infertility. Beyond patient morbidity, adhesions impose a substantial economic burden, with adhesiolysis costing an estimated $1.3 billion annually in the United States alone.
While laparoscopic surgery was initially expected to eliminate adhesion formation due to its minimally invasive nature, evidence suggests that while it generally reduces adhesiogenesis compared to open laparotomy, it does not eliminate it. Unique factors of laparoscopy—such as pneumoperitoneum-induced hypoxemia and high intraabdominal pressure—can actually promote adhesion formation. Prevention requires a combination of meticulous surgical technique, minimizing insufflation duration and pressure, and the targeted use of adhesion-prevention adjuvants.
Clinical and Economic Significance
Postoperative adhesions are a leading cause of long-term surgical morbidity and mortality. Their impact is categorized across several domains:
Small Bowel Obstruction (SBO): Adhesions cause 75% of all SBO cases. They account for 2% of all surgical admissions and 3% of all laparotomies.
Surgical Complications: Adhesions complicate reoperations by increasing the risk of inadvertent enterotomy (occurring in 19% of patients in one study), which subsequently leads to higher rates of anastomotic leaks and wound infections.
Infertility: Pelvic adhesions are identified as a significant cause of infertility in women.
Economic Impact: In the United States, the direct cost of patient care associated with the lysis of adhesions is estimated at $1.3 billion per year. In the United Kingdom, approximately 50,000 operations annually are performed solely for adhesiolysis.
Pathophysiology of Adhesion Formation
Adhesion formation is the result of an imbalance between fibrin deposition and fibrinolysis following peritoneal injury.
The Formation Process
Initial Insult: Abrasion, cutting, ischemia, desiccation, or coagulation triggers an inflammatory response.
Inflammatory Response: This stage is characterized by hyperemia, fluid exudation, and the production of proinflammatory cytokines. The complement and coagulation cascades are activated.
Fibrin Deposition: Inflammatory exudate rich in fibrinogen is converted to fibrin by thrombin, creating a bridge between adjoining damaged surfaces.
Fibroblast Infiltration: Within days, migrating fibroblasts infiltrate the fibrin matrix in response to chemoattractants. They deposit extracellular matrix (ECM) materials, such as collagen, converting "fibrinous" (temporary) adhesions into "fibrous" (permanent) adhesions.
The Role of Fibrinolysis
The peritoneum possesses inherent fibrinolytic activity that can degrade fibrin before it becomes a permanent fibrous adhesion.
The Balance: The early balance between fibrin formation and degradation is the primary determinant of whether an adhesion persists.
Regulatory Factors: Injury impairs fibrinolytic activity by depleting tissue plasminogen activator (tPA) and increasing plasminogen activator inhibitor (PAI). Transforming growth factor beta-1 (TGF-b1) also plays a critical role by reducing fibrinolytic activity and promoting fibroblast proliferation.
Laparoscopy and Adhesion Formation
Laparoscopic surgery is generally less "adhesiogenic" than open surgery, but it introduces unique physiological stressors that can contribute to adhesion formation.
Advantages of Laparoscopy
Reduced Trauma: Minimizes the use of retractors, packs, sponges, and glove powder.
Closed Environment: Reduces peritoneal desiccation by limiting exposure to room air.
Tissue Handling: Results in less visceral damage and decreased need for blind dissection.
Peristalsis: Earlier recovery of peristalsis may help mechanically disrupt early fibrinous adhesions.
Unique Laparoscopic Risk Factors
Comparative Evidence: Open vs. Laparoscopic Surgery
The effectiveness of laparoscopy in reducing adhesions varies across clinical and experimental studies.
Animal Models: Most studies (canine, rat, pig) show a reduction in adhesions with laparoscopy, particularly regarding adhesions to the abdominal wall and enteroenteric adhesions. However, results are variable due to differing species and grading methods.
Human Gynecologic Studies:
The Operative Laparoscopic Study Group found that 66 of 68 women had recurrence of adhesions after laparoscopic adhesiolysis.
However, the incidence of de novo (new) adhesions was significantly lower (8/68) compared to historical data for open surgery (50%).
General Surgery Studies:
Cholecystectomy: Patients undergoing laparoscopic cholecystectomy had fewer adhesions at the operative and incision sites compared to open procedures.
Appendectomy: One randomized trial showed an adhesion incidence of 10% for laparoscopic vs. 80% for conventional open surgery.
Small Bowel Obstruction (SBO) Post-Laparoscopy: A multicenter study found that 50% of SBO cases following laparoscopy were caused by adhesions, while the other 50% were caused by bowel incarceration at port sites. The prevalence of early SBO appears similar between laparoscopic and open abdominal procedures.
Prevention and Management Strategies
To minimize the risk of postoperative adhesions, surgeons should adhere to strict technical principles and utilize adjuvants when appropriate.
Surgical Techniques
Minimize Pneumoperitoneum Stress: Use the lowest possible intraabdominal pressure and minimize the duration of insufflation.
Moisture Maintenance: Use adequate irrigation to avoid desiccation of the mesothelial layers.
Tissue Care: Employ gentle tissue manipulation and ensure meticulous hemostasis (blood can interfere with fibrinolysis).
Adhesion Prevention Adjuvants
While many products exist for open surgery, their application in laparoscopy varies in ease and efficacy:
Physical Barriers:
Sepafilm (sodium hyaluronate-based): Effective but difficult to apply via a laparoscope.
Interceed (oxidized regenerated cellulose): Can be applied laparoscopically but is ineffective in the presence of blood.
Emerging Technologies: Liquid or gel-based adjuvants are more suited for laparoscopic delivery. Examples include:
Polyethylene glycol hydrogel.
SprayGel.
ACP gel.